Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Japan approves Bristol Myers Squibb’s B-cell lymphoma therapy

pharmaceutical-business-reviewMarch 31, 2021

Tag: Breyanzi , Bristol Myers Squibb , MHLW , LBCL

PharmaSources Customer Service